You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice

Citation Tools

Article menu

Download PDFPDF

XML
Metabolism
Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hsieh P, Ho H, Hsieh S, et al
Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice
BMJ Open Diabetes Research and Care 2020;8:e001028. doi: 10.1136/bmjdrc-2019-001028